Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib

BACKGROUND: Pain is a core domain of psoriatic arthritis (PsA). This post hoc analysis evaluated time to pain improvement and the impact of baseline pain severity on pain response in patients with PsA receiving tofacitinib. METHODS: Data from two trials (NCT01877668; NCT01882439) in patients receivi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:RMD Open
Asıl Yazarlar: de Vlam, Kurt, Ogdie, Alexis, Bushmakin, Andrew G, Cappelleri, Joseph C, Fleischmann, Roy, Taylor, Peter C, Azevedo, Valderilio, Fallon, Lara, Woolcott, John, Mease, Philip J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2021
Konular:
Psoriatic Arthritis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8258668/
https://ncbi.nlm.nih.gov/pubmed/34226183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2021-001609
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller